Barkin Berk (Barkın Berk)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Single Molecule

Molecular Docking

Cognitive Impairment

Top Venues

Turkish journal of chemistry

Drug development research

Journal of oncology

Zeitschrift fur Naturforschung. C, Journal of biosciences

This page only lists publications with an associated author ORCID identifier.

Publications

Zafer Sahin, Yağmur Özhan, Hande Sipahi, Sevde Nur Biltekin Kaleli, Leyla Yurttaş, Barkin Berk, Şeref Demirayak
Novel benzofurane-pyrazole derivatives with anti-inflammatory, cyclooxygenase inhibitory and cytotoxicity evaluation. Zeitschrift fur Naturforschung. C, Journal of biosciences 77 (7-8) (2022)
Asmita Priyadarshini Khatiwada, Melike Koçoğlu Kalkan, Barkin Berk, Leyla Yurttaş, Ceysu Bender, Sevde Nur Biltekin Kaleli, Şeref Demirayak
Synthesis, characterization, COX1/2 inhibition and molecular modeling studies on novel 2-thio-diarylimidazoles. Turkish journal of chemistry 45 (6) (2021)
Necdet Üskent, Şule Ayla, Nil Molinas Mandel, Metin Ozkan, Mehmet Teomete, Huseyin Baloglu, Cenk Aydıncer, Hale Yergok, Ender Doğan, Barkin Berk, Aziz Yazar
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. Journal of oncology 2020 (2020)
Merve Ertas, Zafer Sahin, Emre F Bulbul, Ceysu Bender, Sevde N Biltekin, Barkin Berk, Leyla Yurttaş, Aysu M Nalbur, Hayati Celik, Şeref Demirayak
Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives. Archiv der Pharmazie 352 (11) (2019)
Zafer Sahin, Merve Ertas, Ceysu Bender, Emre F Bülbül, Barkin Berk, Sevde N Biltekin, Leyla Yurttaş, Şeref Demirayak
Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors. Drug development research 79 (8) (2018)